Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MMED

MiniMed Group Inc

May 27 • 02:51PM ET

10.87

-0.31 -2.76 %

Healthcare • Health Information Services • USA • Mid • NASD

Peers: EVH PHR DH DOCS GDRX TDOC HQY AMWL LFMD HIMS

| Held by: FPX ONEQ GINN MMID

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	90.05%	Shs Outstand	280.82M	Perf Week	-0.17%
Market Cap	3.05B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	27.94M	Perf Month	-15.86%
Enterprise Value	3.10B	PEG	-	EPS next Q	-	Inst Own	11.56%	Short Float	13.08%	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	32.47%	Short Ratio	3.60	Perf Half Y	-
Sales	-	P/B	0.88	EPS next Y	-	ROA	-	Short Interest	3.66M	Perf YTD	-41.20%
Book/sh	12.33	P/C	305.29	EPS next 5Y	-	ROE	-	52W High	20.48 -46.92%	Perf Year	-
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	10.65 2.08%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.37% 6.22%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.77	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.01	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	35.99	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	1.59	EPS Q/Q	-	SMA20	-5.58%	Beta	-	Target Price	21.67
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-18.67%	Rel Volume	0.45	Prev Close	11.18
Employees	-	LT Debt/Eq	0.01	Earnings	Jun 03 BMO	SMA200	-21.51%	Avg Volume	1.02M	Price	10.87
IPO	Mar 06, 2026	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	381,794	Change	-2.76%

Date	Action	Analyst	Rating Change	Price Target Change
May-12-26	Initiated	The Benchmark Company	Buy	$20
Mar-31-26	Initiated	William Blair	Outperform
Mar-31-26	Initiated	Wells Fargo	Overweight	$26
Mar-31-26	Initiated	Piper Sandler	Neutral	$16
Mar-31-26	Initiated	Morgan Stanley	Overweight	$19
Mar-31-26	Initiated	Mizuho	Outperform	$21
Mar-31-26	Initiated	Goldman	Buy	$24
Mar-31-26	Initiated	Evercore ISI	Outperform	$20
Mar-31-26	Initiated	Deutsche Bank	Buy	$20
Mar-31-26	Initiated	Citigroup	Buy	$23
Mar-31-26	Initiated	BTIG Research	Buy	$25
Mar-31-26	Initiated	BofA Securities	Buy	$27

Show Previous Ratings

Today 09:07AM	MiniMed to Showcase MiniMed Flex and MiniMed Go at the American Diabetes Association Scientific Sessions (PR Newswire)
May-26-26 08:45AM	MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire) -5.81%
May-21-26 08:33AM	New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System (PR Newswire)
May-12-26 09:56AM	Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls (The Fly) +6.54%
Apr-28-26 09:05AM	MiniMed announces Health Canada License for Simplera Sync Sensor, Type 2 Diabetes Indication with MiniMed 780G System (GlobeNewswire)
04:01PM	Loading…
Apr-13-26 04:01PM	MiniMed to announce financial results for its fourth quarter and full fiscal year 2026 (PR Newswire) +5.70%
Mar-31-26 03:09PM	MiniMed initiated with Buy rating by Bank of America on pipeline-driven growth outlook (Proactive)
09:32AM	Western Digital upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly)
Mar-18-26 09:06AM	MiniMed Announces FDA Clearance of MiniMed Flex, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design (PR Newswire)
Mar-09-26 04:59PM	MiniMed announces closing of Initial Public Offering (PR Newswire)
Mar-06-26 09:00AM	MiniMed to begin trading on Nasdaq Global Select Market (PR Newswire)
09:00AM	MiniMed begins trading on Nasdaq Global Select Market (PR Newswire)

MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.

CEO & DirectorMs. Que Thanh Dallara

Executive VP and Chief Product & Technology OfficerMr. Ali Dianaty

SVPMs. Courtney Nelson Wills

Senior VP & Chief Human Resources OfficerMs. Gillian Chandrasena

PresidentMr. Christopher E. Eso

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MMED

MiniMed Group Inc

Upgrade your Finviz experience